BioMed Research International

Neurodegeneration: Etiologies and New Therapies

Publishing date
26 Sep 2014
Submission deadline
09 May 2014

Lead Editor

1Department of Neurology, Singapore General Hospital, National Neuroscience Institute and Duke NUS Graduate Medical School, Singapore

2Russell H. Morgan Department of Radiology and Radiological Science and Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

3Department of Neurology, Division of Neuromuscular Medicine, and Department of Physical Medicine and Rehabilitation, The Ohio State University, Columbus, OH 43210, USA

4Toxicogenomics and Predictive Toxicology Division, CSIR-Indian Institute of Toxicology Research, Lucknow, Uttar Pradesh 226 001, India

5Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA

Neurodegeneration: Etiologies and New Therapies


Neurodegeneration is seen in many nervous system disorders such as Alzheimer’s disease, amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis, cerebral stroke, Huntington’s disease, and several other neurological conditions. These diseases have devastating effects on patients and are often accompanied by tremendous physical and emotional burden not only for the patients but also for their families and friends as well. These disorders are not only amongst the most costly diseases to society but also their increasing prevalence poses a serious public health problem. Just three decades ago very little was known about the causes of neurodegeneration. However, several breakthroughs in recent years have provided some notable insights. Although substantial progress has been made, more detailed studies are needed to understand the cause and molecular mechanisms of neurodegeneration in order to identify potential targets and to provide corrective interventions in addition to supportive treatments.

In this special issue, we invite investigators to contribute original research articles and reviews exploring molecular mechanism of neurodegeneration, new diagnostic tools, and innovative approaches for treatment. Potential topics include, but are not limited to:

  • New in vivo and in vitro models to study neurodegeneration
  • Development and validation of biomarkers to improve the diagnosis
  • New risk factors for neurodegenerative diseases
  • Neurochemistry and/or molecular mechanisms of neurodegeneration
  • New therapeutic targets for treatment
  • Stem cell and gene-based therapies in neurodegenerative disorders

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
Journal Citation Indicator0.610
Impact Factor3.411

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.